GLP-1 drugs add something new to your system. Our technology enhances what’s already there,” Muchnick said. While NotCo’s ...

Right now, about 12% of American aged 18 or older (or 1 in 8 adults) are taking GLP-1 — glucagon-like peptide-1 — receptor ...

GLP-1 medications are changing the way we approach weight loss and chronic conditions. Dr. Nima Mowzoon of UBI Telehealth ...

Medications like Ozempic and Mounjaro work by mimicking naturally occurring hormones in the body, such as glucagon-like ...

Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...

In recent years, GLP-1 for weight loss has emerged as a significant breakthrough, capturing the attention of both healthcare providers and individuals struggling with obesity. Glucagon-like peptide-1 ...

What’s the difference between a compounded GLP-1 drug and a brand-name one? As mentioned, pharmacy compounding is meant to serve a few specific purposes, namely the creation of a custom form of ...

With GLP-1 weight loss comes muscle loss. Gyms and personal trainers are rising to the challenge to help people build it back ...

Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...

if they’ve been taking a compounded copy of a [GLP-1] drug, that era is coming to an end.” It’s a hard reality for patients to accept. Online, some wonder what’s different now, months after the ...

You may soon be able to eat your Ozempic … sort of. GLP-1 supplements are booming, promising to deliver similar benefits to Ozempic and Wegovy without the pricey injections. The latest contender ...